Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity.
Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity.
复制标题
作者:
In obesity and type 2 diabetes, Glut4 glucose transporter expression is decreased selectively in adipocytes. Adipose-specific knockout or overexpression of Glut4 alters systemic insulin sensitivity. Here we show, using DNA array analyses, that nicotinamide N-methyltransferase (Nnmt) is the most strongly reciprocally regulated gene when comparing gene expression in white adipose tissue (WAT) from adipose-specific Glut4-knockout or adipose-specific Glut4-overexpressing mice with their respective controls. NNMT methylates nicotinamide (vitamin B3) using S-adenosylmethionine (SAM) as a methyl donor. Nicotinamide is a precursor of NAD+, an important cofactor linking cellular redox states with energy metabolism. SAM provides propylamine for polyamine biosynthesis and donates a methyl group for histone methylation. Polyamine flux including synthesis, catabolism and excretion, is controlled by the rate-limiting enzymes ornithine decarboxylase (ODC) and spermidine–spermine N1-acetyltransferase (SSAT; encoded by Sat1) and by polyamine oxidase (PAO), and has a major role in energy metabolism. We report that NNMT expression is increased in WAT and liver of obese and diabetic mice. Nnmt knockdown in WAT and liver protects against diet-induced obesity by augmenting cellular energy expenditure. NNMT inhibition increases adipose SAM and NAD+ levels and upregulates ODC and SSAT activity as well as expression, owing to the effects of NNMT on histone H3 lysine 4 methylation in adipose tissue. Direct evidence for increased polyamine flux resulting from NNMT inhibition includes elevated urinary excretion and adipocyte secretion of diacetylspermine, a product of polyamine metabolism. NNMT inhibition in adipocytes increases oxygen consumption in an ODC-, SSAT- and PAO-dependent manner. Thus, NNMT is a novel regulator of histone methylation, polyamine flux and NAD+-dependent SIRT1 signalling, and is a unique and attractive target for treating obesity and type 2 diabetes.
登录
查看更多内容
DOI:
10.1126/science.1226603
发表时间:
2013-01-11
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Shyh-Chang N;Locasale JW;Lyssiotis CA;Zheng Y;Teo RY;Ratanasirintrawoot S;Zhang J;Onder T;Unternaehrer JJ;Zhu H;Asara JM;Daley GQ;Cantley LC
通讯作者:
Cantley LC
DOI:
10.1007/978-1-61779-034-8_1
发表时间:
2011
期刊:
Methods in molecular biology (Clifton, N.J.)
影响因子:
--
作者:
Pegg, Anthony E;Casero, Robert A Jr
通讯作者:
Casero, Robert A Jr
影响因子:
29
作者:
Eguchi, Jun;Yan, Qing-Wu;Rosen, Evan D.
通讯作者:
Rosen, Evan D.
DOI:
10.1152/ajpheart.00717.2011
发表时间:
2012-02-01
影响因子:
4.8
作者:
Bubolz, Aaron H.;Mendoza, Suelhem A.;Zhang, David X.
通讯作者:
Zhang, David X.
影响因子:
64.8
作者:
Rodgers, JT;Lerin, C;Puigserver, P
通讯作者:
Puigserver, P